CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | Sigal Charles Elliott Director | Purchase | +2,500 | $22.73 | $57K | 10,000 |
| 2023-01-05 | Sigal Charles Elliott Director | Purchase | +2,500 | $24.96 | $62K | 7,500 |
| 2023-01-04 | Sigal Charles Elliott Director | Purchase | +2,500 | $25.25 | $63K | 5,000 |
| 2023-01-03 | Sigal Charles Elliott Director | Purchase | +2,500 | $25.60 | $64K | 2,500 |
| 2021-11-29 | HANLY ANN M. Chief Technology Officer | Purchase | +11.52 | $43.39 | $500 | 11.52 |
Page 1 of 1 · 5 trades